359 related articles for article (PubMed ID: 18698239)
1. Human leukocyte antigen antibodies and chronic rejection: from association to causation.
Terasaki PI; Cai J
Transplantation; 2008 Aug; 86(3):377-83. PubMed ID: 18698239
[TBL] [Abstract][Full Text] [Related]
2. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
Lee PC; Zhu L; Terasaki PI; Everly MJ
Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
[TBL] [Abstract][Full Text] [Related]
3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
4. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
5. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
6. Monitoring and treating posttransplant human leukocyte antigen antibodies.
Everly MJ; Terasaki PI
Hum Immunol; 2009 Aug; 70(8):655-9. PubMed ID: 19375466
[TBL] [Abstract][Full Text] [Related]
7. A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients.
Kimball PM; King A
Clin Transpl; 2011; ():369-72. PubMed ID: 22755433
[TBL] [Abstract][Full Text] [Related]
8. Detailed examination of HLA antibody development on renal allograft failure and function.
Zhu L; Lee PC; Everly MJ; Terasaki PI
Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
[TBL] [Abstract][Full Text] [Related]
9. The role of the histocompatibility laboratory in desensitization for transplantation.
Leffell MS; Zachary AA
Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655
[TBL] [Abstract][Full Text] [Related]
10. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients.
Everly MJ
Clin Transpl; 2011; ():333-6. PubMed ID: 22755427
[TBL] [Abstract][Full Text] [Related]
11. Summary of the effect of de novo HLA antibodies on chronic kidney graft failure.
Terasaki P; Lachmann N; Cai J
Clin Transpl; 2006; ():455-62. PubMed ID: 18365403
[TBL] [Abstract][Full Text] [Related]
12. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
13. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients.
Fuggle SV; Martin S
Transplantation; 2008 Aug; 86(3):384-90. PubMed ID: 18698240
[TBL] [Abstract][Full Text] [Related]
14. Desensitization and heart transplantation of a patient with high levels of donor-reactive anti-human leukocyte antigen antibodies.
Bućin D; Gustafsson R; Ekmehag B; Kornhall B; Algotsson L; Lund U; Otto G; Koul B
Transplantation; 2010 Dec; 90(11):1220-5. PubMed ID: 20885338
[TBL] [Abstract][Full Text] [Related]
15. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
[TBL] [Abstract][Full Text] [Related]
16. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients.
Everly MJ
Clin Transpl; 2011; ():319-25. PubMed ID: 22755425
[TBL] [Abstract][Full Text] [Related]
17. [Role of antibodies in kidney transplant].
Ruffoni E; Seveso M; Marson P; Tison T; Cozzi E
G Ital Nefrol; 2012; 29 Suppl 54():S54-60. PubMed ID: 22388831
[TBL] [Abstract][Full Text] [Related]
18. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
Cheng EY; Kaneku H; Farmer DG
Clin Transpl; 2014; ():153-9. PubMed ID: 26281140
[TBL] [Abstract][Full Text] [Related]
19. Progress in understanding humoral rejection in kidney transplantation: implications for patient management.
Pascual MA; Crespo M; Tolkoff-Rubin N
Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504
[TBL] [Abstract][Full Text] [Related]
20. Annual literature review of donor-specific HLA antibodies after organ transplantation.
Kaneku H
Clin Transpl; 2011; ():311-8. PubMed ID: 22755424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
